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Abstract
Background: CT-guided fine needle bioptic procedures (CTFNP) are characterised by low
invasiveness, precise sample collection, a high diagnostic efficiency and support a rapid diagnostic
process. A number of different fine needles and bioptic procedures are mainly used for tumour
diagnostics today.
The aim of the present study was to characterise the most important technical issues of fine needle
bioptic procedures. In addition, we directly compared the diagnostic outcome and reliability of the
most commonly used Rotex Screw Needle – (RSN) and Yale Needle – (YN) bioptic procedure.
Methods: In an experimental part of the study, using pig spleen, we measured the maximum
number of sampled cells using different needles and aspiration volumes.
For the clinical questions we analysed all consecutive 340 patients in which CTFNP were
performed between 1/97–12/05 in the hospital Grosshansdorf. We evaluated the number of
adverse events based on all clinical available information and compared the cytological findings with
the respective final diagnosis (confirmed: clinically n = 192, histologically n = 148).
Results: Using the YN with at least some negative pressure we found a proportional increase of
cell and tissue recovery with increasing number of needle movements.
A sensitivity of 78% and a specificity 98% indicate a high diagnostic outcome of CTFNP. We found
no statistical significant difference in terms of sensitivity (80 vs. 68%) as well as complication rates
(5.9 vs. 4.4%) between RSN or YN.
Conclusion: As fine needle basically works like a cutting instrument, it is possible to raise the cell/
tissue recovery. Keeping this in mind we found a high diagnostic outcome of CTFNP, which was
largely independent of needle type and bioptic technique, and comparable with other conventional
bioptic procedures.
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Fine needle biopsy is a well established and a commonly
used procedure in tumour diagnostics. In addition to the
conventional endoscopic and percutaneous fine needle
punctures there is an increasing interest in the use of flex-
ible endosonographic ultrasound giuded fine needle aspi-
ration biopsies. Based on the main technical principle the
large number of different needles can be grouped into
core-, cutting- and aspiration needles. Core- and cutting
needle specimens are generally suitable for embedding
and histological analysis, while aspiration needle speci-
men comprise most often smaller cell and tissue frag-
ments, which should be evaluated by cytology. It has to be
considered that most needles work by applying at least
two functional principles; e.g. a YN both cuts and aspi-
rates. Despite the long tradition of fine needle biopsy
diagnostics, very little is known about the exact mecha-
nisms that influence the quality and the outcome of the
procedure.
The aim of the present study was therefore to answer the
following questions: (1) Which are the technical factors
relevant for successful use of RSN and YN? (2) What is the
rate of adverse events using RSN and YN? (3) What is the
diagnostic outcome of CT-guided RSN- and YN-punctures
in benign and malign thoracic lesions?
Methods
Fine needles
The fine needles used in this study are shown in figure 1
and listed in table 1. The Rotex Screw Needle was supplied
by Ursus Konsultant AB (Stockholm, Sweden), the Yale-
Spinal-Needle by Becton Dickinson GmbH (Heidelberg,
Germany), the Vacu-Cut-Needle and the Auto-Vac-Needle
by BARD GmbH/Angiomed (Karlsruhe, Germany), and
the Venipuncture Needle acc. to Strauss by B Braun (Mel-
sungen Germany).
Experimental part
First we measured the negative pressure obtained with dif-
ferent needles at different evacuation volumes (20 and 50
ml) and for different needle lengths. Next we determined
the influence of needle handling (number of punctures)
at maximum negativ pressure, on the sampled cell
number using the YN and the RSN. These experiments
were performed using fresh pig spleen tissue. The revealed
cells were stained by trypan blue and total cell counts were
assessed in a Neubauer chamber. For control cytospin
slides were prepared from 50,000 cells (600 cpm, 15 min;
Heraeus Sepatech Omnifuge 2.0 RS; Heraeus Sepatech,
Hanau, Germany) and stained with May-Gruenwald-
Giemsa for the cytological examination.
Clinical part
The clinical part of the study was based on the data of all
consecutive patients undergoing CT-guided fine needle
bioptic procedures at the hospital Großhansdorf in the
period from January 1997 to December 2005. In total we
included 340 patients (243 m, 97 f). To determine the
diagnostic outcome we compared the cytological result of
74 RSN- and 364 YN-biopsies with 192 clinically and 148
(132 specimens obtained during surgery) histologically
verified final diagnosis. In addition, we determined the
number of adverse events during and at least 24 hours
after the procedure.
For each fine needle bioptic procedure the needle was
inserted at least three times and a cytological analysis was
performed for each of these samples. If at least in one of
these samples malignant cells or cells of uncertain dignity
were found the cytological diagnosis was malignant or
uncertain. If in none of the samples malignant cells or
cells of uncertain dignity were found the cytological diag-
nosis was benign.
Data analysis
Median values and quartiles of cell numbers were com-
puted and compared by Mann-Whitney-U test. Sensitivity,
specificity and diagnostic reliability were computed as
usual. Sensitivity and specificity were compared between
different criteria by the Fishers exact test or the one-sided
test of proportions, if appropriate. Statistical significance
was assumed for p < 0.05.
Results
Experimental results
Although the majority of fine needles depend on the gen-
eration of a negative pressure there are remarkable differ-
ences between manufactors and needle models. Entering
the Autovac and Vacu cut needles into pig spleen it was
possible to generate only very limited negative pressure
(always below 80 mbar, fig. 2). In contrast to these nee-
dles we measured a maximum negative pressure of 940
mbar and 931 mbar using the venipuncture needles acc.
to Strauss or the YN respectively (fig. 2).
Table 1: Outer diameter, length and costs of different bioptic 
needles
Model Ø in mm Length in mm costs in Germany
Rotex Screw Needle 0.8 90 58.90 €
Yale Spinal Needle 0.7 90 1.33 €
Vacu Cut Needle 0.8 100 18.41 €
Vacu Cut Needle 0.8 200 18.41 €
Autovac Needle 0.95 150 19.17 €
Venipuncture 
Needle acc. to 
Strauss
1.5 43 5.33 €Page 2 of 5
(page number not for citation purposes)
Diagnostic Pathology 2007, 2:31 http://www.diagnosticpathology.org/content/2/1/31The main aim of fine needle biopsies is to collect a mini-
mum required number of cells to allow a cytological anal-
ysis. With a single insertion of the RSN into a pig spleen
we sampled a median (range) number 0.85 × 106 (0.83–
0.87) cells. This needle needs to be pulled out after each
bioptic procedure to release the cell specimen prior to the
next insertion.
In contrast to RSN the YN does not need to be pulled out
completely and can be insert into the tumour repeatedly
by small needle movements. The number of these move-
ments was directly proportional to the number of aspi-
rated cells. Applying a sufficient negative pressure during
these movements has further increase the efficacy of the
YN. There were no differences between 20 ml or 50 ml
aspiration volumes (fig. 3).
Clinical results
We performed 438 fine needle biopsies in 340 patients,
using the YN in 364 cases. In the majority of cases (n =
192) the final diagnosis was based on clinical findings
and follow up. In 148 cases it was based on an independ-
ently performed histological analysis.
In 200 of 266 patients (75.2 %) with malignant tumours,
the tumour was detected by cytology. In 61 of 62 patients
with benign lesions the cytological analysis of fine needle
bioptic material was able to determine the correct under-
lying dignity. Only in 12 patients neither clinical informa-
tion (n = 10) nor histological analysis (n = 2) were able to
find the correct dignity of the lesion.
Overall CTFNP of pulmonary lesions showed a sensitivity
of 78 % and a specificity 98 % resulting in a diagnostic
reliability of 77 % (table 2). CTFNP in the cases, in which
the final diagnosis was confirmed clinically, showed a bet-
ter sensitivity and specificity as compared to the histolog-
ically confirmed cases. However, neither in the clinical
nor in the histologically validated cases a significant dif-
ference between YN and RSN could be detected (Fishers
exact test p = 0.34; Tab. 2).
It is well known, that the success of a bioptic procedure
critically depends on the sampling accuracy. Therefore the
size of the lesion is important, and there should be a rela-
tionship between the volume of a tumour and the diag-
nostic reliability of the applied method.
In 132 resected tumours we were able to determine the
exact tumour size and volume respectively. Below a
tumour volume of 20 cm3 we found a much lower sensi-
tivity and lower diagnostic reliability as compared to
larger tumours (Fishers exact Test p = 0.016; Tab. 3).
Rate of adverse events
The main adverse event of fine needle biopsy are a pneu-
mothorax and intrapulmonal hemorrhage. In this study
we observed a pneumothorax in 5.5 % of patients (9/
163). All these were very small and only detectable by CT.
Table 2: CTFNP – Sensitivity, specificity and diagnostic 
reliability




192 84.6 100.0 83.9
YN 164 83.0 100.0 82.9
RSN 28 91.7 100.0 89.3
Histology 148 70.8 93.8 68.2
YN 114 68.0 92.3 66.7
RSN 34 80.0 100.0 73.5
Total 340 77.8 98.4 77.1
Different fine needle typesFigu  1
Different fine needle types.
Pressure-time-curves with different needles and different ne dle l ngth using evacuation volum s of 20 and 50 mlFigure 2
Pressure-time-curves with different needles and different 
needle length using evacuation volumes of 20 and 50 ml.Page 3 of 5
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rax which was detectable by conventional X-ray. Only in 7
of these patients it was necessary to apply a drainage. The
rate of adverse events was not different between RSN- and
YN-biopsies (5.9 vs. 4.4%) (Fishers exact test p = 0.291;
Table 4).
Discussion
In order to optimize the outcome of fine needle biopsy it
is important to keep in mind, that all needles basically
work like cutting instruments. Here we were able to show,
that first of all the extend of needle movements raise the
cell/tissue recovery and result in a high diagnostic out-
come of CTFNP, which is even comparable with other
conventional bioptic procedures. Both sensitivity and spe-
cificity, as well as complication rates were largely inde-
pendent of needle type and bioptic technique.
In the recent years, cytology of the respiratory tract has
been revolutionized by a high degree of sophistication in
radiologic technology and sonography, making a precise
visualization and localization of tumours in the lungs,
bronchi, mediastinum or chest wall possible. Between
1997 and 2005 the files of the hospital Großhandorf
cytology laboratory recorded a total of 9380 fine needle
specimens (4847 rapid on site analysis). Basically any
patient found to have a demonstrable radiolographic
tumour is a potential candidate for a fine needle biopsy. A
further decision on whether or not to proceed with this
procedure is usually based on the morphologic evidence
provided by prior cytologic and histologic specimens
obtained from the respiratory tract and on the clinical rel-
evance of morphological findings.
From all fine needle specimens several direct smears are
prepared and air dryed. One of these smears will be cho-
sen for rapid or standard Giemsa staining. Because of
direct sampling within the tumour by a fine needle, these
specimen most often contain large numbers of cancer
cells and tissue fragments, leaving generally additional
unstained slides for further routine- or immuncytological
staining procedures. Despite that, the amount of material
as well as the number of slides are usually limited and
occasionally there are 9 patients (2.6 % in our case), in
whom a cancer is suspected but can not be conclusively
diagnosed by cytology alone.
In pneumology CTFNP are well established diagnostic
procedures and in clinical practise a number of different
needles are used. Despite of all technical differences all
fine needles have in common that they function like a cut-
ting instrument. In addition, turning and repeated punc-
ture movements help to gain small cell clusters and tissue
fragments. Although a applied negative pressure can assist
in raising the amount of cells, this factor is of limited
importance compared to the effect of cutting. This would
explain that although a large differences in negative pres-
sure between needle types exist (fig. 1), we found a similar
diagnostic outcome with NN and YN. In addition, the
number and handling of repeated punctures influenced
the success of a fine needle biopsy, as we were able to
show in our experiments with pig spleen (fig. 2).
Table 4: CTFNP – pneumothorax-rate RSN and YN (exclusively 
patients with histologically verified final diagnosis, n = 148)
RSN YN
Number of patients 34 114
Pneumothorax rate % (n) rate % (n)
According CT-findings 8.8 (3) 14.0 (16)
According Conventional X-ray 14.7 (5) 9.7 (11)
Thorax drainage necessary 5.9 (2) 4.4 (5)
Pig spleen model – fine needle biopsy: number of harvested cell  v rsus needle type and handling (median and range)Fi ur  3
Pig spleen model – fine needle biopsy: number of harvested 
cells versus needle type and handling (median and range). 
Squares = YN without negative pressure, tri-angles = YN 
using 20 ml aspiration volume, diamonds = YN using 50 ml 
aspiration volume, circles = Rotex Screw Needle.
Table 3: Sensitivity, specificity and diagnostic reliability vs. 









<10 44 57.1 85.7 56.8
10–20 21 57.9 100.0 61.9
20–30 13 83.3 100.0 76.9
30–70 19 77.8 100.0 73.7
>70 35 84.8 100.0 80.0Page 4 of 5
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The sensitivity and the diagnostic outcome of fine needle
biopsy seems to be independent from the kind of mor-
phological analysis (histology or cytology) and have been
reported to range between 62%–83% (at a specificity of
100%) and 68%–85%, respectively [1-3]. Both with the
YN and the RSN, which were used in this study, we found
a very similar diagnostic outcome of 77 % as compared to
the literature [4-6]. CTFNP therefore did not differ from
conventional cut needle or forceps biopsies [7]. The diag-
nostic outcome, however, depends on the size of the tar-
get. In line with others [1] we also found that the increase
of the diagnostic outcome corresponded to the tumour
volume (table 3). This would also explain better values for
sensitivity and specificity in group of patients with clini-
cally verified tumours, as these tend to be larger in size as
compared to those with histologically verified final diag-
nosis (table 2).
The most common complication of CTFNP are haemor-
rhage or the occurrence of a potentially drainage requiring
pneumothorax. It is well known that the risk of such com-
plications increase with the outer diameter of the needle.
Using fine needles with a diameter > 1 mm leads to pneu-
mothorax rates of more than 13 % [3,8]. Experienced cli-
nicians, on the other hand, are able to keep the
complication rate significantly lower, especially if needles
with smaller calibre are used. In our study we recorded
adverse events in only 6 % of all cases, with no differences
between RSN and YN, which is in accordance with [4].
As shown in table 1 there are quite large differences in the
costs of different needle types. We would like to empha-
sise that a clinician should always be working with a nee-
dle type he is familiar/experienced with, as, in the time of
restricted hospital budgets, it could be argued that only
low price needles should be used. With respect to the
complication rate it is our experience that it increases with
larger needles. In line with the literature we would there-
fore also recommend needles with outer diameter below
0.8 mm [8].
Conclusion
In summary we would like to emphasize that a fine needle
basically works like a cutting instrument, and repeated
needle movements are of prime importance for both cells/
tissue quantity and quality. In line with others we found
that the diagnostic outcome of CTFNP was high. In addi-
tion we were able to demonstrate that the outcome was
largely independent of needle type and bioptic technique,
and comparable with other conventional bioptic proce-
dures.
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